Can-Fite BioPharma Ltd. Revenue from Contract with Customer, Including Assessed Tax
Can-Fite BioPharma Ltd. (CANF) reported Revenue from Contract with Customer, Including Assessed Tax of $743.00 thousand for the 12-month period ending 2023-12-31, per its 20-F filed 2024-03-28.
Financial Statements › Income Statement › Revenue
us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax · last filed 2026-03-26
USD
| Period end | Revenue from Contract with Customer, Including Assessed Tax | Revenue from Contract with Customer, Including Assessed Tax 12 month |
|---|---|---|
| 2023-12-31 | $743.00K 20-F · filed 2024-03-28 | |
| 2022-12-31 | $810.00K 20-F · filed 2024-03-28 | |
| 2021-12-31 | $853.00K 20-F · filed 2024-03-28 | |
| 2019-07-31 | $750.00K 20-F · filed 2026-03-26 |
EUR
| Period end | Revenue from Contract with Customer, Including Assessed Tax 12 month |
|---|---|
| 2023-12-31 | 1.50M EUR 20-F · filed 2025-04-14 |